JP2025500805A5 - - Google Patents

Info

Publication number
JP2025500805A5
JP2025500805A5 JP2024534461A JP2024534461A JP2025500805A5 JP 2025500805 A5 JP2025500805 A5 JP 2025500805A5 JP 2024534461 A JP2024534461 A JP 2024534461A JP 2024534461 A JP2024534461 A JP 2024534461A JP 2025500805 A5 JP2025500805 A5 JP 2025500805A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
heavy chain
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500805A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/086097 external-priority patent/WO2023111157A1/en
Publication of JP2025500805A publication Critical patent/JP2025500805A/ja
Publication of JP2025500805A5 publication Critical patent/JP2025500805A5/ja
Pending legal-status Critical Current

Links

JP2024534461A 2021-12-16 2022-12-15 ヒトｎｇｆに対するイヌ化およびネコ化抗体 Pending JP2025500805A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163290264P 2021-12-16 2021-12-16
US63/290,264 2021-12-16
US202263327076P 2022-04-04 2022-04-04
US63/327,076 2022-04-04
PCT/EP2022/086097 WO2023111157A1 (en) 2021-12-16 2022-12-15 Caninized and felinized antibodies to human ngf

Publications (2)

Publication Number Publication Date
JP2025500805A JP2025500805A (ja) 2025-01-15
JP2025500805A5 true JP2025500805A5 (https=) 2025-12-19

Family

ID=84888668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024534461A Pending JP2025500805A (ja) 2021-12-16 2022-12-15 ヒトｎｇｆに対するイヌ化およびネコ化抗体
JP2024534470A Pending JP2025500806A (ja) 2021-12-16 2022-12-15 ヒトｎｇｆに対するイヌ化抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024534470A Pending JP2025500806A (ja) 2021-12-16 2022-12-15 ヒトｎｇｆに対するイヌ化抗体

Country Status (7)

Country Link
US (2) US20250340626A1 (https=)
EP (2) EP4448568A1 (https=)
JP (2) JP2025500805A (https=)
AU (2) AU2022409611A1 (https=)
CA (2) CA3240904A1 (https=)
MX (2) MX2024007091A (https=)
WO (2) WO2023111157A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
FR3149894A1 (fr) 2023-06-13 2024-12-20 Saint-Gobain Centre De Recherches Et D'etudes Europeen Grain fondu à base d’alumine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
EP0216846B2 (en) 1985-04-01 1995-04-26 Celltech Limited Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
US6548062B2 (en) 2000-02-29 2003-04-15 Cephalon, Inc. Method of treating cancer with anti-neurotrophin agents
CA2975521A1 (en) 2001-05-30 2002-12-05 Genentech, Inc. Anti-ngf antibodies for the treatment of various disorders
AR045056A1 (es) 2003-07-15 2005-10-12 Amgen Inc Anticuerpos anti-ngf humanos neutralizantes como inhibidores selectivos de la via de ngf
MX2010001395A (es) 2007-08-10 2010-03-10 Regeneron Pharma Anticuerpos humanos de alta afinidad de factor de crecimiento de nervio humano.
CA2875783C (en) * 2012-06-06 2018-12-11 Zoetis Llc Caninized anti-ngf antibodies and methods thereof
CN106029697B (zh) 2013-12-20 2021-06-04 英特维特国际股份有限公司 具有经修饰的ch2-ch3序列的犬抗体
BR112020017701A2 (pt) * 2018-03-12 2020-12-29 Zoetis Services Llc Anticorpos anti-ngf e métodos dos mesmos

Similar Documents

Publication Publication Date Title
CN113354729B (zh) 一种抗新型冠状病毒的单克隆抗体及其应用
JP2022079549A5 (https=)
JP2024109678A5 (https=)
CN105315371B (zh) 抗人il-17单克隆抗体
RU2012112829A (ru) Анти-gitr-антитела
JP2021526022A5 (https=)
FI3390451T3 (fi) Kaninisoidut ihmisen vasta-aineet ihmisen ja koiraeläimen il-4r alfaa kohtaan
RU2009120052A (ru) Композиции и способы связывания сфингозин-1-фосфата
RU2016119152A (ru) Стабильные и растворимые антитела, ингибирующие vegf
JP2024056817A5 (https=)
JP2005518336A5 (https=)
JP2020505927A5 (https=)
RU2008106893A (ru) Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
JP2023530663A5 (https=)
JP2020505919A5 (https=)
JP2022540083A5 (https=)
JP2025500805A5 (https=)
JP2010509931A5 (https=)
CN110869390A (zh) 抗pd-l1抗体及其用途
JP2023093753A5 (https=)
CN113354730B (zh) 一种抗新型冠状病毒的单克隆抗体及其应用
JP2025500806A5 (https=)
JP2021501579A5 (https=)
JP2022538232A5 (https=)
JP2021517459A5 (https=)